| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.081 | 0.09 |